Bone Marrow Transplant in Treating Patients With Hematologic Cancers
Completed · Phase 2
Conditions studied: Chronic Myeloproliferative Disorders, Leukemia, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
In brief
RATIONALE: Giving chemotherapy drugs and total-body irradiation before a donor bone marrow transplant helps stop the growth of cancer cells. It also helps stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. PURPOSE: This phase II trial is studying how well donor bone marrow transplant works in treating patients with hematologic cancers.
Key facts
- Study ID
- NCT00005797
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
- People needed
- 125
- Starts
- 1993-03-01
- Expected to finish
- 2007-07-01
- Last updated by the study team
- 2020-12-10
Who can join
Age: 15 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.